Australia’s Drug Regulator Grants Pfizer Vaccine Provisional Approval for 5-11 Year Olds

Pfizer/BioNTech's new pediatric COVID-19 vaccine vials are seen in this undated handout photograph. Pfizer via Reuters

A coronavirus vaccine for children as young as five has taken a step closer in Australia to being recommended and could be available early in the new year.

The Therapeutic Goods Administration has given its provisional approval for Pfizer’s COVID-19 vaccine for five to 11 year olds.